
Dasashil 70mg is a prescription cancer medicine that contains Dasatinib, a tyrosine kinase inhibitor (TKI), and it is primarily used in the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
| Generic Name | Dasatinib |
| Manufacturer | Shilpa Medicare Ltd |
| Packing | 60 Tablets in 1 Bottle |
| Prescribed For | Blood Cancer |
| Availability | In Stock |




As a trusted provider of high-quality generic anticancer medicines, we offer authentic Dasashil (Dasatinib 70mg) Tablets, commonly prescribed for the treatment of Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL).
We guarantee safe, timely, and consistent bulk supply of oncology drugs, including Dasatinib (Generic Sprycel), to hospitals, clinics, pharmacies, healthcare providers, physicians, NGOs, and authorized buyers in over 80 countries worldwide. Our global distribution network spans Latin America, Africa, Asia, Europe, the Middle East, and North America, covering key markets such as Mexico, Brazil, Colombia, Peru, Chile, UAE, Saudi Arabia, Egypt, South Africa, Namibia, Kenya, Nigeria, Singapore, Vietnam, Thailand, the Philippines, Canada, and many more.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.